Molekylserbiologisk diagnostik og monitorering ved akut lymfoblastaer leukaemi og ved non-Hodgkin-lymfom

Ugeskrift for Laeger

Volumn 158, Issue 49, 1996, Pages 7101-7102

  Svejgaard, Arne ^a   Madsen, Hans O ^a   Nyrold, Charlotte ^a   Ryder, Lars P ^a   Schmiegelow, Kjeld ^a  

^a Rigshospitalet

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR BIOLOGY; MONITORING; NONHODGKIN LYMPHOMA;

HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MOLECULAR BIOLOGY; MONITORING, PHYSIOLOGIC;

EID: 0030566391     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Svejgaard A. Molekylærbiologi og immunologi. Ugeskr Læger 1995; 157: 867-8.
2. Stewart AK, Schwartz RS. Immunoglobulin V regions and the B cell. Blood 1994; 83: 1717-30.
3. Aisenberg AC. Utility of gene rearrangements in lymphoid malignancies. Annu Rev Med 1993; 44: 75-84.
4. Potter MN. The detection of minimal residual disease in acute lymphoblastic leukaemia Blood Rev 1993; 6: 68-82.
5. Brisco MJ, Condon J, Hughes E, Neoh S-H, Sykes PJ, Seshadri R et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 1994; 343: 196-200.